{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:49Z","timestamp":1781650789390,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472015"],"award-info":[{"award-number":["82472015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402318"],"award-info":[{"award-number":["82402318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92259303"],"award-info":[{"award-number":["92259303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hospitals Authority's Ascent Plan","award":["DFL20241103"],"award-info":[{"award-number":["DFL20241103"]}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W032150102"],"award-info":[{"award-number":["BRWEP2024W032150102"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2409405"],"award-info":[{"award-number":["2022YFC2409405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Physician Scientist Training Program","award":["BJPSTP-2025-21"],"award-info":[{"award-number":["BJPSTP-2025-21"]}]},{"name":"Beijing Natural Science Foundation","award":["L252055"],"award-info":[{"award-number":["L252055"]}]},{"name":"CAMS Medical and Health Science and Technology Innovation","award":["2021-I2M-5-002"],"award-info":[{"award-number":["2021-I2M-5-002"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-C&T-B-1202"],"award-info":[{"award-number":["2022-I2M-C&T-B-1202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08152-8","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:45:12Z","timestamp":1777257912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics profiling of NECTIN4 in lung cancer and comparative evaluation of NECTIN4-targeted \u2076\u2078Ga-N188 and \u00b9\u2078F-FDG PET\/CT"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-7550","authenticated-orcid":false,"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"8152_CR1","first-page":"394","volume":"68","author":"B Freddie","year":"2018","unstructured":"Freddie B, Jacques, Ferlay, Isabelle S, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"8152_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1164\/rccm.200504-531OE","volume":"172","author":"SG Spiro","year":"2005","unstructured":"Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med. 2005;172:523\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"8152_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2214\/AJR.19.21227","volume":"213","author":"A Kandathil","year":"2019","unstructured":"Kandathil A, Sibley RC III, Subramaniam RM. Lung Cancer Recurrence: (18)F-FDG PET\/CT in Clinical Practice. AJR Am J Roentgenol. 2019;213:1136\u201344.","journal-title":"AJR Am J Roentgenol"},{"key":"8152_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.semnuclmed.2025.02.005","volume":"55","author":"B Cangut","year":"2025","unstructured":"Cangut B, Akinlusi R, Mohseny A, Ghesani N, Ghesani M. Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals. Semin Nucl Med. 2025;55:264\u201376.","journal-title":"Semin Nucl Med"},{"key":"8152_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12935-022-02669-w","volume":"22","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li G, Zhang Y, Li L, Zhang Y, Huang X, et al. Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K\/AKT\/NF-\u03baB signaling by down-regulation of miR-520c-3p. Cancer Cell Int. 2022;22:252.","journal-title":"Cancer Cell Int"},{"key":"8152_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.humpath.2017.10.034","volume":"72","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Chen P, Yin W, Ji Y, Shen Q, Ni Q. Nectin-4 promotes gastric cancer progression via the PI3K\/AKT signaling pathway. Hum Pathol. 2018;72:107\u201316.","journal-title":"Hum Pathol"},{"key":"8152_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2016.02.049","volume":"375","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang Z, et al. A novel PI3K\/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth. Cancer Lett. 2016;375:179\u201389.","journal-title":"Cancer Lett"},{"key":"8152_CR8","doi-asserted-by":"publisher","first-page":"24895","DOI":"10.18632\/oncotarget.4366","volume":"6","author":"T Fujiyuki","year":"2015","unstructured":"Fujiyuki T, Yoneda M, Amagai Y, Obayashi K, Ikeda F, Shoji K, et al. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells. Oncotarget. 2015;6:24895\u2013903.","journal-title":"Oncotarget"},{"key":"8152_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lungcan.2021.11.016","volume":"163","author":"S Marks","year":"2022","unstructured":"Marks S, Naidoo J. Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach. Lung Cancer. 2022;163:59\u201368.","journal-title":"Lung Cancer"},{"key":"8152_CR10","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","volume":"69","author":"A Takano","year":"2009","unstructured":"Takano A, Ishikawa N, Nishino R, Masuda K, Yasui W, Inai K, et al. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 2009;69:6694\u2013703.","journal-title":"Cancer Res"},{"key":"8152_CR11","doi-asserted-by":"publisher","first-page":"174516","DOI":"10.1016\/j.ejphar.2021.174516","volume":"911","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Sinha S, Kundu CN. Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy. Eur J Pharmacol. 2021;911:174516.","journal-title":"Eur J Pharmacol"},{"key":"8152_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.eururo.2022.01.032","volume":"81","author":"B McGregor","year":"2022","unstructured":"McGregor B, O\u2019Donnell PH, Balar A, Petrylak D, Rosenberg J, Yu EY, et al. Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1\/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial. Eur Urol. 2022;81:515\u201322.","journal-title":"Eur Urol"},{"key":"8152_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1200\/JCO.19.02044","volume":"38","author":"J Rosenberg","year":"2020","unstructured":"Rosenberg J, Sridhar SS, Zhang J, Smith D, Ruether D, Flaig TW, et al. EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma. J Clin Oncol. 2020;38:1041\u20139.","journal-title":"J Clin Oncol"},{"key":"8152_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.euo.2024.02.010","volume":"7","author":"DJ Benjamin","year":"2024","unstructured":"Benjamin DJ, Rezazadeh Kalebasty A, Prasad V. The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma? Eur Urol Oncol. 2024;7:313\u20135.","journal-title":"Eur Urol Oncol"},{"key":"8152_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1158\/1535-7163.MCT-21-0875","volume":"21","author":"M Rigby","year":"2022","unstructured":"Rigby M, Bennett G, Chen L, Mudd GE, Harrison H, Beswick PJ, et al. BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Mol Cancer Ther. 2022;21:1747\u201356.","journal-title":"Mol Cancer Ther"},{"key":"8152_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1470-2045(21)00094-2","volume":"22","author":"EY Yu","year":"2021","unstructured":"Yu EY, Petrylak DP, O\u2019Donnell PH, Lee JL, van der Heijden MS, Loriot Y, et al. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV\u2013201): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2021;22:872\u201382.","journal-title":"Lancet Oncol"},{"key":"8152_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11307-016-0953-x","volume":"18","author":"DO Campbell","year":"2016","unstructured":"Campbell DO, Noda A, Verlinsky A, Snyder J, Fujita Y, Murakami Y, et al. Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys. Mol Imaging Biol. 2016;18:768\u201375.","journal-title":"Mol Imaging Biol"},{"key":"8152_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12951-022-01444-3","volume":"20","author":"F Shao","year":"2022","unstructured":"Shao F, Pan Z, Long Y, Zhu Z, Wang K, Ji H, et al. Nectin-4-targeted immunoSPECT\/CT imaging and photothermal therapy of triple-negative breast cancer. J Nanobiotechnol. 2022;20:243.","journal-title":"J Nanobiotechnol"},{"key":"8152_CR19","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/acs.molpharmaceut.4c00366","volume":"21","author":"Q Wan","year":"2024","unstructured":"Wan Q, Yuan H, Cai P, Liu Y, Yan T, Wang L, et al. Effects of PEGylation on Imaging Contrast of (68)Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4. Mol Pharm. 2024;21:4430\u201340.","journal-title":"Mol Pharm"},{"key":"8152_CR20","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1158\/1078-0432.CCR-23-0609","volume":"29","author":"X Duan","year":"2023","unstructured":"Duan X, Xia L, Zhang Z, Ren Y, Pomper MG, Rowe SP, et al. First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET\/CT Imaging of Advanced Urothelial Carcinoma. Clin Cancer Res. 2023;29:3395\u2013407.","journal-title":"Clin Cancer Res"},{"key":"8152_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2967\/jnumed.123.266830","volume":"65","author":"J Zhang","year":"2024","unstructured":"Zhang J, Duan X, Chen X, Zhang Z, Sun H, Shou J, et al. Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with (68)Ga-N188. J Nucl Med. 2024;65:12\u20138.","journal-title":"J Nucl Med"},{"key":"8152_CR22","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"8152_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356.","journal-title":"Genome Res"},{"key":"8152_CR24","doi-asserted-by":"publisher","first-page":"e38663","DOI":"10.1016\/j.heliyon.2024.e38663","volume":"10","author":"K Mohd Kamal","year":"2024","unstructured":"Mohd Kamal K, Ghazali AR, Ab Mutalib NS, Abu N, Chua EW, Masre SF. The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC). Heliyon. 2024;10:e38663.","journal-title":"Heliyon"},{"key":"8152_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11060-010-0520-2","volume":"104","author":"G Rajendran","year":"2011","unstructured":"Rajendran G, Shanmuganandam K, Bendre A, Muzumdar D, Goel A, Shiras A. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas. J Neurooncol. 2011;104:483\u201394.","journal-title":"J Neurooncol"},{"key":"8152_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","volume":"945","author":"R Lakshminarasimhan","year":"2016","unstructured":"Lakshminarasimhan R, Liang G. The Role of DNA Methylation in Cancer. Adv Exp Med Biol. 2016;945:151\u201372.","journal-title":"Adv Exp Med Biol"},{"key":"8152_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12935-023-03074-7","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu C, Tang H, Hu N, Li T. Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. Cancer Cell Int. 2023;23:242.","journal-title":"Cancer Cell Int"},{"key":"8152_CR28","doi-asserted-by":"publisher","first-page":"101268","DOI":"10.1016\/j.jpha.2025.101268","volume":"15","author":"Y Chai","year":"2025","unstructured":"Chai Y, Shi Y. The role of genetics and epigenetics in breast cancer: A comprehensive review of metastasis, risk factors, and future perspectives. J Pharm Anal. 2025;15:101268.","journal-title":"J Pharm Anal"},{"key":"8152_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-11454-0_1","volume":"1389","author":"RZ Jurkowska","year":"2022","unstructured":"Jurkowska RZ, Jeltsch A. Mechanisms and Biological Roles of DNA Methyltransferases and DNA Methylation: From Past Achievements to Future Challenges. Adv Exp Med Biol. 2022;1389:1\u201319.","journal-title":"Adv Exp Med Biol"},{"key":"8152_CR30","doi-asserted-by":"crossref","unstructured":"Kim DJ. The role of the DNA methyltransferase family and the therapeutic potential of DNMT inhibitors in tumor treatment. Curr Oncol. 2025;32.","DOI":"10.3390\/curroncol32020088"},{"key":"8152_CR31","doi-asserted-by":"publisher","first-page":"958146","DOI":"10.3389\/fphar.2022.958146","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Yang F, Zhang L, Hu Y, Chen B, Wang J, et al. Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Front Pharmacol. 2022;13:958146.","journal-title":"Front Pharmacol"},{"key":"8152_CR32","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1038\/s41598-022-07727-x","volume":"12","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Murata M, Tanegashima K, Oda Y, Ito T. Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma. Sci Rep. 2022;12:4031.","journal-title":"Sci Rep"},{"key":"8152_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1158\/1535-7163.MCT-21-0846","volume":"21","author":"W Bouleftour","year":"2022","unstructured":"Bouleftour W, Guillot A, Magne N. The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review. Mol Cancer Ther. 2022;21:493\u2013501.","journal-title":"Mol Cancer Ther"},{"key":"8152_CR34","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1038\/s41467-024-52915-0","volume":"15","author":"Y Loriot","year":"2024","unstructured":"Loriot Y, Kamal M, Syx L, Nicolle R, Dupain C, Menssouri N, et al. The genomic and transcriptomic landscape of metastastic urothelial cancer. Nat Commun. 2024;15:8603.","journal-title":"Nat Commun"},{"key":"8152_CR35","doi-asserted-by":"publisher","first-page":"176129","DOI":"10.1016\/j.ejphar.2023.176129","volume":"960","author":"H Wang","year":"2023","unstructured":"Wang H, Sun D, Chen J, Li H, Chen L. Nectin-4 has emerged as a compelling target for breast cancer. Eur J Pharmacol. 2023;960:176129.","journal-title":"Eur J Pharmacol"},{"key":"8152_CR36","doi-asserted-by":"crossref","unstructured":"Liu Y, Han X, Li L, Zhang Y, Huang X, Li G, et al. Role of Nectin\u20134 protein in cancer (Review). Int J Oncol. 2021;59.","DOI":"10.3892\/ijo.2021.5273"},{"key":"8152_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00432-019-03055-2","volume":"146","author":"C Sethy","year":"2020","unstructured":"Sethy C, Goutam K, Nayak D, Pradhan R, Molla S, Chatterjee S, et al. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse. J Cancer Res Clin Oncol. 2020;146:245\u201359.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8152_CR38","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1200\/JCO.23.01983","volume":"42","author":"N Kl\u00fcmper","year":"2024","unstructured":"Kl\u00fcmper N, Tran NK, Zsch\u00e4bitz S, Hahn O, B\u00fcttner T, Roghmann F, et al. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. J Clin Oncol. 2024;42:2446\u201355.","journal-title":"J Clin Oncol"},{"key":"8152_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00439-013-1373-5","volume":"133","author":"L Sim\u00f3-Riudalbas","year":"2014","unstructured":"Sim\u00f3-Riudalbas L, Esteller M. Cancer genomics identifies disrupted epigenetic genes. Hum Genet. 2014;133:713\u201325.","journal-title":"Hum Genet"},{"issue":"3","key":"8152_CR40","first-page":"588","volume":"10","author":"C KESK\u0130N","year":"2025","unstructured":"KESK\u0130N C, ARAS \u0130O, BARAN MF, TOPG\u0130DER BARANA, ASYALI \u00d6. Prunus cerasus (Vi\u015fne) Meyvesinden Elde Edilen \u00d6z\u00fctlerin Antimikrobiyal, Antikolinesteraz Aktivitelerinin ve Fenolik Bile\u015fenlerinin Ara\u015ft\u0131r\u0131lmas\u0131. MAS J Appl Sci. 2025;10(3):588\u201399.","journal-title":"MAS J Appl Sci"},{"key":"8152_CR41","doi-asserted-by":"publisher","first-page":"188961","DOI":"10.1016\/j.bbcan.2023.188961","volume":"1878","author":"Z Han","year":"2023","unstructured":"Han Z, Yi X, Li J, Zhang T, Liao D, You J, et al. RNA m(6)A modification in prostate cancer: A new weapon for its diagnosis and therapy. Biochim Biophys Acta Rev Cancer. 2023;1878:188961.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8152_CR42","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/cac2.70052","volume":"45","author":"F Tian","year":"2025","unstructured":"Tian F, Huang J, Fan W, Li X, Zhan Y, Zhu K, et al. m(6)A-modified EHD1 controls PD-L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma. Cancer Commun (Lond). 2025;45:1285\u2013308.","journal-title":"Cancer Commun (Lond)"},{"key":"8152_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00018-025-05875-7","volume":"82","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Huang Q, Yuan X, Xu Y, Xu C, Guo Y, et al. m6A-mediated upregulation of miR-3690 drives HNSCC progression by regulating nuclear-cytoplasmic signaling pathway. Cell Mol Life Sci. 2025;82:379.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"8152_CR44","first-page":"1182","volume":"9","author":"F Alan","year":"2025","unstructured":"Alan F, \u00c7olak AM. Phytochemical and antioxidant characterization of myrtle (Myrtus communis L.) fruit. ISPEC J Agric Sci. 2025;9(4):1182\u201393.","journal-title":"ISPEC J Agric Sci"},{"key":"8152_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01243894-200601000-00014","volume":"1","author":"JF Vansteenkiste","year":"2006","unstructured":"Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol. 2006;1:71\u20133.","journal-title":"J Thorac Oncol"},{"key":"8152_CR46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/radiol.2482071822","volume":"248","author":"CA Yi","year":"2008","unstructured":"Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET\/CT versus 3.0-T whole-body MR imaging. Radiology. 2008;248:632\u201342.","journal-title":"Radiology"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08152-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:46:17Z","timestamp":1781649977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08152-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8152"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08152-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8063844\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Peking University Cancer Hospital (2022KT37-ZY01). This article does not contain any experiments with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research patients provided informed consent for publication of the images in Figs.\u00a0\n                      \n                      and\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}